Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy OPKO Health stock in Canada | $4.3

Own OPKO Health shares in just a few minutes.

Updated . What changed?

Fact checked

OPKO Health, Inc is a diagnostics & research business based in the US. OPKO Health shares (OPK.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.3 – a decrease of 6.93% over the previous week. OPKO Health employs 6,096 staff and has a trailing 12-month revenue of around $1.2 billion.

How to buy shares in OPKO Health

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: OPK in this case.
  5. Research OPKO Health shares. The platform should provide the latest information available.
  6. Buy your OPKO Health shares. It's that simple.

How has Coronavirus impacted OPKO Health's share price?

Since the stock market crash in March caused by coronavirus, OPKO Health's share price has had significant positive movement.

Its last market close was $4.3, which is 62.09% up on its pre-crash value of $1.63 and 225.76% up on the lowest point reached during the March crash when the shares fell as low as $1.32.

If you had bought $1,000 worth of OPKO Health shares at the start of February 2020, those shares would have been worth $933.34 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,866.68.

OPKO Health share price

Use our graph to track the performance of OPK stocks over time.

OPKO Health shares at a glance

Information last updated 2020-12-02.
Latest market close $4.3
52-week range $1.1171 - $6.47
50-day moving average $3.9949
200-day moving average $3.7927
Wall St. target price $8
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.424

Compare online trading platforms

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost
Wealthsimple Trade
Stocks, ETFs
Buy and sell thousands of US and Canadian stocks and ETFs commission-free with Wealthsimple Trade.
Interactive Brokers
Stocks, Bonds, Options, Mutual Funds, ETFs, Currencies, Futures, Precious Metals
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are equal to or greater than US$10.00)
Min. $1.00, Max. 0.5% of trade value
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, IPOs, Precious Metals
$4.95 - $9.95
$9.95 + $1 per contract
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.

Compare up to 4 providers

Name Product Minimum deposit to invest Funding methods Management fee Available asset types
CI Direct Investing (formerly WealthBar)
Direct deposit, Bank transfer
0.35% - 0.60%
Mutual Funds, ETFs
CI Direct Investing offers access to an exclusive and personalized investment portfolio. Get up to $10,000 managed free for a year when you sign up for your first CI Direct Investing account and fund your account.
Automatic bank withdrawals
The Moka app rounds up every purchase you make to the nearest dollar and invests the spare change into low-cost exchange-traded funds (ETFs).
Direct deposit, Bank transfer, Automatic bank withdrawals
Receive a cash bonus of $50.00-$225.00 when you open a new Justwealth account. RESP accounts require no minimum deposit to begin investing.
Wealthsimple Invest
Direct deposit, Bank transfer
0.40% - 0.50%
Stocks, Bonds, ETFs, Commodities
Get a $50 bonus when you open and fund your first Wealthsimple Invest account with a minimum initial deposit of at least $500. Trade and Cash accounts are not eligible.

Compare up to 4 providers

Name Product Minimum Opening Deposit Commission Available Markets Platforms
Minimum US$25
Shares Desktop, Web Trading, Mobile Trading, MetaTrader 4
CFDs are leveraged products which involves greater risk than using cash resources only. You could lose all or more of your initial investment. Trade 80+ currency pairs and 220+ CFDs in equities, commodities and indices on

Compare up to 4 providers

Is it a good time to buy OPKO Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

OPKO Health price performance over time

Historical closes compared with the last close of $4.3

1 week (2020-11-25) 8.86%
1 month (2020-11-02) 24.28%
3 months (2020-09-02) 31.50%
6 months (2020-06-02) 77.69%
1 year (2019-12-02) 175.64%
2 years (2018-11-30) 14.97%
3 years (2017-12-01) -17.47%
5 years (2015-12-02) -61.64%

Is OPKO Health under- or over-valued?

Valuing OPKO Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of OPKO Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.


OPKO Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$65 million.

The EBITDA is a measure of a OPKO Health's overall financial performance and is widely used to measure a its profitability.

OPKO Health financials

Revenue TTM USD$1.2 billion
Gross profit TTM USD$264.9 million
Return on assets TTM -0.6%
Return on equity TTM -6.99%
Profit margin -9.79%
Book value $2.424
Market capitalisation USD$2.9 billion

TTM: trailing 12 months

How to short and sell OPKO Health shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "OPK.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 130.2 million OPKO Health shares held short by investors – that's known as OPKO Health's "short interest". This figure is 4.1% down from 135.8 million last month.

There are a few different ways that this level of interest in shorting OPKO Health shares can be evaluated.

OPKO Health's "short interest ratio" (SIR)

OPKO Health's "short interest ratio" (SIR) is the quantity of OPKO Health shares currently shorted divided by the average quantity of OPKO Health shares traded daily (recently around 10.1 million). OPKO Health's SIR currently stands at 12.9. In other words for every 100,000 OPKO Health shares traded daily on the market, roughly 12900 shares are currently held short.

However OPKO Health's short interest can also be evaluated against the total number of OPKO Health shares, or, against the total number of tradable OPKO Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OPKO Health's short interest could be expressed as 0.19% of the outstanding shares (for every 100,000 OPKO Health shares in existence, roughly 190 shares are currently held short) or 0.3251% of the tradable shares (for every 100,000 tradable OPKO Health shares, roughly 325 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against OPKO Health.

Find out more about how you can short OPKO Health stock.

OPKO Health share dividends

We're not expecting OPKO Health to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

OPKO Health share price volatility

Over the last 12 months, OPKO Health's shares have ranged in value from as little as $1.1171 up to $6.47. A popular way to gauge a stock's volatility is its "beta".

OPK.US volatility(beta: 1.93)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OPKO Health's is 1.9284. This would suggest that OPKO Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

OPKO Health overview

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, a selective androgen receptor modulator; and OPK88003, a once or twice weekly oxyntomodulin that is in Phase IIb trials for type 2 diabetes and obesity. It is also developing hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc.; VARUBI for chemotherapy-induced nausea and vomiting; and Factor VIIa drug for hemophilia. In addition, this segment develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, it develops, manufactures, markets, and sells pharmaceutical, nutraceutical, and veterinary products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. Additionally, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site